B. Riley Starts CytoSorbents (CTSO) at Buy
- Wall St. set to open flat as earnings season gathers pace
- Alibaba (BABA) Tops Q3 EPS by 17c, Revenues Rise 54%
- DuPont (DD) Tops Q4 EPS by 9c; Sees Merger Closing in First Half
- Johnson & Johnson (JNJ) Tops Q4 EPS by 2c; Guides Modestly Below the Street
- Barclays Downgrades Apple (AAPL) to Equalweight, Concerned India/China Will not Emerge As Growth Catalysts
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
B. Riley initiated coverage on CytoSorbents (NASDAQ: CTSO) with a Buy rating and a price target of $11.25.
Shares of CytoSorbents closed at $5.63 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CytoSorbents (CTSO) PT Raised to $10 at Maxim Group
- Berenberg Starts Deere (DE) at Sell
- Janney Montgomery Scott Starts FS Investment (FSIC) at Neutral
Create E-mail Alert Related CategoriesNew Coverage
Related EntitiesB. Riley
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!